Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Stem Cell Therapy Market is expected to generate a revenue of USD 31.41 Billion…
Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=24113 Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=24113 Browse in-depth TOCon" Stem Cell Therapy Market " 202 - Pages 126 – Tables 37 – Figures Report Scope Global Stem Cell Therapy Market Overview Key Market Drivers in shaping the market Advancements in Regenerative Medicine : Breakthroughs in regenerative medicine, driven...
PR Newswire
12/08/2024
Momcozy's Ongoing Campaign for Breastfeeding Awareness Month Connects Moms and…
Breastfeeding is worth celebrating. That is why Momcozy teamed up with Pumpspotting, the American College of Nurse-Midwives, and District Motherhood for a celebration event at Chaia Georgetown in Washington D.C. on August 9. Titled "Nurture & Be Nourished: A Celebration of Breastfeeding Journeys," the event allowed participants to connect with midwives, lactation consultants, and other breastfeeding families. A mini session with The Portrait Mama was also available to capture the…
PR Newswire
12/08/2024
Junshi Biosciences Announces Acceptance of Supplemental New Drug Application for…
Melanoma is the most malignant type of skin cancer. According to the 2022 GLOBOCAN Report, approximately 332,000 new melanoma cases and approximately 59,000 deaths were recorded globally that year. Though melanoma is relatively uncommon in China, its mortality rate is high (5,000 deaths amongst approximately 9,000 new cases in 2022) and its incidence rate is rising year by year. So far, anti-PD-1 monoclonal antibodies have only been approved for the second-line or beyond treatment of...
Nasdaq GlobeNewswire
12/08/2024
Acousia Therapeutics to present its clinical Phase 2 PROHEAR study on hearing…
On August 21, Dr. Jonas Dyhrfjeld-Johnsen will be presenting the Phase 2 PROHEAR clinical study on ACOU085 at the industry-leading 4th Inner Ear Disorders Therapeutics Summit organized by HansonWade in Boston (MA) in the Discovering & Validating Brand-New Drug Targets For Noise-Induced, Age-Related & Chemically-Induced Deafness session. In addition, Dr. Dyhrfjeld-Johnsen will be chairing the Summit and participating in roundtable and panel discussions. OnAugust 21, Dr. Jonas...
PR Newswire
12/08/2024
Novo Nordisk A/S – Share repurchase programme
Bagsværd, Denmark, 12 August 2024– On 7 August 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 20 billion to be executed during a 12-month period beginning 6 February 2024. Under the...
Nasdaq GlobeNewswire
12/08/2024
Orion Corporation: Managers' transactions – Satu Ahomäki
ORION CORPORATIONMANAGERS' TRANSACTIONS12 AUGUST 2024 at 15.30 EEST Orion Corporation: Managers' transactions – Satu Ahomäki Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.Orion Oyj - Managers' Transactions____________________________________________Person subject to the notification...
Nasdaq GlobeNewswire
12/08/2024
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives…
Bagsværd, Denmark, 12 August 2024— This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse. The company's board members, executives and their associated persons have reported the transactions to Novo Nordisk and have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk...
Nasdaq GlobeNewswire
12/08/2024
Evaxion to Announce Business Update and Second Quarter 2024 Financial Results on…
/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will provide a business update and report its second quarter 2024 financial results on Wednesday, August 14, 2024, before opening of the Nasdaq-CM. Evaxion's Executive Management will host a conference call and webcast the same day at 14:30 CEST/08:30 EDT presenting the update and results as well as taking questions. This event is free, open to the...
Nasdaq GlobeNewswire
12/08/2024
Animal Health Industry to Witness Exponential Growth from 2023 to 2030: Grand…
The Livestock Monitoring Market was estimated at USD 4.01 billion in 2023 and is anticipated to grow at a CAGR of 11.56% from 2024 to 2030. This is a growing sector that leverages technology to improve animal health, productivity, and overall farm management. Key trends in this market include wearable technologies, artificial intelligence, and others. The AI in livestock monitoring is expanding as technology advances and farmers seek more efficient and data-driven ways to manage their herds. AI…
PR Newswire
12/08/2024
Buyback of Class B shares in Essity during week 32, 2024
The share repurchase is financed using cash flow from current operations after the ordinary dividend with the ambition to continue with share buybacks over time as a recurring part of Essity's capital allocation. The share repurchase is financed using cash flow from current operations after the ordinary dividend with the ambition to continue with share buybacks over time as a recurring part of Essity's capital allocation. Class B shares in Essity were repurchased as follows: All purchases...
PR Newswire
12/08/2024
Discover The Beauty Of Exquisite Materials With KML Worktops' Range Of…
At KML worktops, we have constantly been achieving high-quality worktops since our establishment in 2003. With such history, complex jobs are always executed with high standards thanks to our experienced staff crafting all sorts of different stones to meet each individual needs. At KML worktops, we have constantly been achieving high-quality worktops since our establishment in 2003. With such history, complex jobs are always executed with high standards thanks to our experienced staff…
PR Newswire
12/08/2024
Bio X Cell Announces CEO Appointment
Mr. Conway has extensive experience in both small molecule and Biologics drug discovery, most recently as President of Research and Development (R&D) at Curia. Chris joined Curia (formerly AMRI) in 2008 from Johnson & Johnson and progressed through a series of commercial leadership roles. In 2015 he was promoted to Senior Vice President and Drug Discovery and Development Business Unit Head. He led that business through a period of significant organic and inorganic growth culminating in…
PR Newswire
12/08/2024
Sandoz receives FDA approval for Enzeevu™ (aflibercept-abzv), further…
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Enzeevu™ (aflibercept-abzv) approved to treat neovascular age-related macular degenerationFurther enhances leading US ophthalmology portfolio and increases access for patientsExpected to be key biosimilar growth driver in USBasel, August 12, 2024 –Sandoz (SIX:SDZ/OTCQX:SDZNY), the global leader in generic and biosimilar medicines, today announced that the US Food and Drug Administration (FDA) has approved...
Nasdaq GlobeNewswire
12/08/2024
German Stem Cell Expert Leads Delegation to Boost Sino-German Health &…
Prof Chan's appointment as a Senator of the German Federal Association for Economic Development and Foreign Trade (BWA) since 2018, plays a crucial role in fostering economic development and foreign trade relations between Germany and key Asian nations. This government-led appointment underscores his international recognition and influence in the field of stem cell research and regenerative medicine in driving cross-border innovations. Prof Chan's appointment as a Senator of the German…
PR Newswire
12/08/2024
Sanofi: Information concerning the total number of voting rights and shares -…
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of theCode de commerce(the French Commercial Code) and article 223-16 of theRèglement général de l'Autorité des Marchés Financiers(Regulation of the French stock market authority) Sanofi a Frenchsociété anonymewith a registered share capital of 2,537,214,304 € Registered office : 46, avenue de la Grande Armée - 75017 Paris - France Registered at the Paris...
Nasdaq GlobeNewswire
09/08/2024
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives…
Bagsværd, Denmark, 9 August 2024— This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse.The company's board members, executives and their associated persons have reported the transactions to Novo Nordisk and have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares...
Nasdaq GlobeNewswire
09/08/2024
CAST Surgical Chosen to Unveil Breakthrough Clinical Follow-up Data at 2024 AAGL…
The innovation behind LevaLap® incorporates a significant advancement in speed and efficiency of precise laparoscopic access, offering new opportunities for standardized abdominal entry. This advancement is set to transform the landscape of minimally invasive laparoscopic entry across multiple fields, including gynecology, urology, general surgery, and robotic surgery. The innovation behind LevaLap ®incorporates a significant advancement in speed and efficiency of precise laparoscopic...
PR Newswire
09/08/2024
Medical Device Engineering Market worth $20.1 billion by 2029 driven by…
Browse in-depth TOC on "Medical Device Engineering Market" Browse in-depth TOC on "Medical Device Engineering Market" 250 - Tables 50 - Figures 300 - Pages L&T Technology Services Limited: Leading Innovator in Medical Device Engineering L&T Technology Services Limited (LTTS) stands out as a top global provider of engineering services, specializing in end-to-end solutions for medical device OEMs. Known for its innovation, LTTS excels in developing cutting-edge...
PR Newswire
09/08/2024
Residential Wooden Doors Market to Reach $74.5 Billion, Globally, by 2032 at…
Prime determinants of growth Prime determinants of growth Demand in the housing market, which includes construction and renovation activities, is strongly influenced by various factors. One of the key factors is consumer preferences for wooden doors, which are determined by style, design and environmental friendliness. In addition, economic conditions such as disposable income and interest rates play a significant role in homeowners' decisions to invest in home improvements....
PR Newswire
09/08/2024
Coway Announces Financial Results for Q2 FY2024
Coway's reported earnings are as follows: Coway's reported earnings are as follows: Cumulative revenue for 2024 now stands at KRW 2,084.1 billion (+6.6% YoY) with an operating profit of KRW 404.9 billion (+9.5% YoY). InSouth Korea, domestic business generatedKRW 655.7 billionin revenue for the second quarter, making an 11.1% increase compared to the previous year. This growth is primarily attributed to the solid rental sales of both BEREX's lineup of mattresses and massage...
PR Newswire
09/08/2024
Press release: Transparency Notification from Shareholders
Transparency Notification from ShareholdersGhent, Belgium – 9 August 2024 – Sequana Medical NV (Euronext Brussels: SEQUA)(the " Company " or " SequanaMedical "), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announces today that it received a transparency notification from the party listed below, notifying the number of voting rights attached to the shares mentioned next to their name in the table below. Reason for notification...
Nasdaq GlobeNewswire
09/08/2024
Voting Rights and Shares Capital of the Company
In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers)PARIS, Aug.08, 2024(GLOBE NEWSWIRE) --Paris, France, August 8, 2024Market: Euronext Paris / Nasdaq Euronext Compartment: BISIN code: FR0011341205 Nasdaq: NBTX Bloomberg: NANO:FP Reuters: NANO.PA Website:www.nanobiotix.comDate Number of Shares OutstandingTotal number of...
Nasdaq GlobeNewswire
08/08/2024
Abzena Supplies Clinical Trial Material for Angiex's Phase I Study of AGX101, a…
Paul Jaminet, co-founder and CEO of Angiex, said: "We are very excited to have dosed our first patient in our first-in-human study of our novel TM4SF1 ADC, AGX101. Throughout the development of AGX101, Abzena has worked closely with us to achieve successful GMP manufacturing and quality control. We could not have reached this milestone without Abzena's expertise, cooperation, and support. Both companies have extensive expertise in their respective fields and an aligned mission, and we look…
PR Newswire
08/08/2024
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives…
Bagsværd, Denmark, 8 August 2024— This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse. The company's board members, executives and their associated persons have reported the transactions to Novo Nordisk and have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk...
Nasdaq GlobeNewswire
08/08/2024
Altri Comunicati
